• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION PRISMAFLEX; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION PRISMAFLEX; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 107493
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Injury (2348)
Event Date 09/25/2019
Event Type  Injury  
Manufacturer Narrative
Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that during continuous renal replacement therapy (crrt) using a prismaflex control unit, the patient experienced an increased calcium level.It was reported the treatment was performed for six days using regional citrate for anticoagulation and calcium was used via an external infusion pump.Crrt was discontinued due to another indication; however, the external calcium infusion was not stopped by the operator at the same time as crrt was stopped.The patient¿s ionized calcium reportedly increased, and an unreported medical intervention was required to treat the hypercalcemic condition.It was reported the event was resolved in 24-48 hours.No clinical symptoms were reported.No additional information is available.
 
Manufacturer Narrative
H10: the device was not returned for evaluation.A service history review revealed no indication that the parts replaced during servicing caused or contributed to the reported event.Based on available information, there was no evidence that a malfunction of the prismaflex caused the reported event.The reported event was caused by a user error as the external calcium infusion pump was not stopped when stopping the continuous renal replacement therapy.Regional citrate anticoagulation is not approved as anticoagulant method when using the prismaflex control unit with software 7.Xx and the control unit is therefore not designed to generate a notification to stop the calcium infusion when an external pumping device is used for calcium infusion.Should additional relevant information become available, a supplemental report will be submitted.
 
Manufacturer Narrative
Correction: removal of information in section f related to importer - the initial report inadvertently included the importer report number.This mdr should have been submitted only with the mfr.Number (and not as importer).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRISMAFLEX
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
MDR Report Key9357102
MDR Text Key185194778
Report Number9616026-2019-00059
Device Sequence Number1
Product Code KDI
Combination Product (y/n)N
PMA/PMN Number
NI
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 11/21/2019,12/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number107493
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA11/21/2019
Distributor Facility Aware Date10/30/2019
Event Location Hospital
Date Report to Manufacturer11/21/2019
Initial Date Manufacturer Received 10/30/2019
Initial Date FDA Received11/21/2019
Supplement Dates Manufacturer Received12/17/2019
12/17/2020
Supplement Dates FDA Received12/19/2019
12/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CALCIUM; EXTERNAL INFUSION PUMP; REGIONAL CITRATE
Patient Outcome(s) Required Intervention;
Patient Age57 YR
-
-